Search

everythinglearnresearchcommunity

for

Search:↓

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

A rare genetic variant linked to skin cysts was found in blood DNA, suggesting its role in cyst formation.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Certain gene variations might be linked to severe acne in women but not in men.

Phytoconstituents from Cyperus Rotundus may help treat hirsutism by interacting with the 5 α reductase enzyme.

A boy with a new NR5A1 gene mutation has a sex development disorder without affecting his adrenal glands.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

A male with aromatase deficiency improved bone health with estradiol treatment.

New genes and pathways are important for testosterone production and male sexual development.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

No link found between specific genes and female pattern hair loss.

CAG repeat length in the AR gene is not linked to PCOS risk in Iranian women.

Non-classical 21-hydroxylase deficiency can be missed in newborn screenings and should be considered in cases of early puberty or virilization.

Finasteride increases P-glycoprotein activity in the liver and kidney.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The same gene mutation can cause different symptoms in family members.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

A new CDH3 gene mutation was found in a Spanish patient with sparse hair and eye issues.

A new genetic variant in the LIPH gene causes hair growth issues in a Chinese patient.

CLEC4D gene variants may increase the risk of alopecia areata in Jordanians.

These medications for BPH have known risks and may have new side effects.